Cancer transcription factor MYC up-regulates the mRNA expression of hnRNPA1 and hnRNPA2 in gliomas, which promotes the synthesis of pyruvate kinase M subtype 2 (PKM2) and participates in glycolytic transformation (Clower et al., 2010). This evidence concerns the gene HNRNPA1 and central nervous system cancer.